
Key Points
- The Lancet reports growing nicotine pouch use in Britain;
- Use among 16- to 24-year-olds rose from 0.7% to 4%;
- Prevalence is highest among young men at 7.5%;
- The UK plans to ban nicotine pouch sales to under-18s;
- Researchers say more evidence is needed on health effects and quit-smoking benefits.
2Firsts, December 17, —— According to a study published in The Lancet, nicotine pouch use is growing in Britain, particularly among young men.
The research found that usage among people aged 16 to 24 rose to 4% in March from 0.7% at the start of 2022, with prevalence highest among young men at 7.5%. This compares with 1% among adults overall.
Nicotine pouches, including Philip Morris International’s Zyn and British American Tobacco’s Velo, have gained popularity across Europe since around 2019, partly because they are perceived as less harmful than cigarettes for delivering nicotine.
Health experts have warned, however, that the tobacco-free pouches carry cardiovascular risks and could act as a gateway to tobacco use for non-smokers. Among pouch users surveyed, 69% reported using other nicotine products, 56% smoked, 39% vaped and 16% said they had never smoked regularly.
The UK government has said it aims to curb use among children through the Tobacco and Vapes Bill, which includes a ban on sales of nicotine pouches to anyone under 18 and packaging rules to reduce youth appeal, while maintaining access for adults seeking to quit smoking.
Among people who attempted to quit smoking in the past year, the proportion using pouches in their most recent attempt rose to 6.5% in March from 2.6% in October 2020. Researchers said further investigation is needed to determine whether nicotine pouches are effective for smoking cessation.
The study used data from University College London’s Smoking Toolkit Study, which surveyed nearly 128,000 people.
Image source: Bloomberg
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com






